Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertension.
Wu WH, Bonnet S, Shimauchi T, Toro V, Grobs Y, Romanet C, Bourgeois A, Vitry G, Omura J, Tremblay E, Nadeau V, Orcholski M, Breuils-Bonnet S, Martineau S, Ferraro P, Potus F, Paulin R, Provencher S, Boucherat O.
Wu WH, et al. Among authors: boucherat o.
Thorax. 2022 Mar;77(3):247-258. doi: 10.1136/thoraxjnl-2021-217377. Epub 2021 Jul 5.
Thorax. 2022.
PMID: 34226205